Mark your calendars for 7:30 p.m. on March 18 to join ISB for a panel discussion about “Tipping Points in Environment and Climate.” The event takes place at Downstairs at Town Hall. Tickets are $5. Info: townhallseattle.org/event/isb-panel Panel description: So-called tipping points — sudden, large-scale environmental changes — are altering our ecosystem in non-intuitive ways that defy our sense of causation. Because the nature of these shifts makes them unexpected,…
ISB announces the appointment of Kathy Scanlan as chief operating officer. Scanlan’s leadership career has spanned government, nonprofits and sports, and includes serving as the Executive Vice-President of the 1990 Seattle Goodwill Games Organizing Committee and as President of USA Gymnastics. Through Scanlan Consulting, her assignments have included working closely with the Washington State Legislature on ferry and transportation issues; strategic and business planning for museums, park facilities, and global health/discovery science…
Congratulations to the Sui Huang Lab at ISB which has received a five-year $1.7 million R01 award from the National Institutes of Health and National Institute for General Medical Sciences to study cancer sub-population dynamics to understand and develop drugs to inhibit lethal cancer-drug resistance. The project proposal states that the work will: “develop a quantitative and formal framework for describing the temporal evolution of cell phenotype distribution in a…
Photos above: (Left) Anne Thompson and (right) Mόnica Orellana as featured in “Women in Oceanography: A Decade Later.” BY ISBUSA Two of ISB’s senior research scientists are featured in the second edition of “Women in Oceanography.” Dr. Mόnica Orellana and Dr. Anne Thompson, both of the Baliga Lab, share their stories about what inspired their careers in oceanography and some of their thoughts about working in the field. The inaugural issue…
ISB announces the appointment of Cynthia Shumate as the chief legal officer and chief compliance officer. She also will serve as the secretary of the ISB’s board of directors. Shumate’s has had a long career as the CLO or CCO of several biotechs, including including a number of notable private corporations including ZetaRx Biosciences (now Juno Therapeutics) and Allozyne, as well as the public company PDL BioPharma. She is a…
